The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2016Identification of Slow Off-rate Modified Aptamer Reagents that Specifically Bind Phosphorylated LRRK2
Study Rationale:
Mutations in the LRRK2 gene are the leading cause of familial Parkinson's disease (PD), often resulting in increased kinase activity and phosphorylation (modification) of several... -
Research Grant, 2016Convergence of LRRK2 and GBA1 in the Pathogenesis of Parkinson's Disease
Study Rationale:
Genetic studies in Parkinson's disease (PD) have led to the discovery of several causal and risk genes, whose mutations contribute to some forms of PD; among those described are... -
Target Advancement Program, 2016Investigation of Lipid Metabolism in GBA-associated Parkinsonism
Study Rationale:
Genetic changes in the glucocerebrosidase (GBA) gene are linked to a higher risk of developing Parkinson's disease (PD) and dementia with Lewy bodies (DLB). These changes in GBA in... -
Improved Biomarkers and Clinical Outcome Measures, 2016Corneal Confocal Microscopy: A Novel Imaging Biomarker for Parkinson's Disease
Study Rationale:
We have pioneered a technique in which we can photograph nerves on the surface of the eye. This technique can be used to monitor the severity of various neurological conditions. In our... -
Target Advancement Program, 2016Assessing the Role of Glucosylceramide in Alpha-synuclein-induced Toxicity
Study Rationale:
Loss-of-function GBA1 mutations in Gaucher disease result in increased risk for Parkinson's disease (PD). Glucocerebrosidase (GCase) normally breaks down a lipid called... -
Target Advancement Program, 2016Assessing the PINK1 Pathway in Parkinson
Study Rationale:
Rare mutations in the PINK1 gene cause familial (inherited) Parkinson's disease (PD). However, it is not known if PINK1 contributes to the development of idiopathic (no known cause) PD...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.